No Data
No Data
Rating information (Target Price change - Part 2) = INPEX, Nifco, etc.
◎ Mizuho Securities (three-tier: Buy > Neutral > Underperform) INPEX <1605.T> -- "Buy" → "Buy", 2200 yen → 2400 yen ALSOK <2331.T> -- "Buy" → "Buy", 1260 yen → 1180 yen Otsuka Shokai <4768.T> -- "Buy" → "Buy", 4200 yen → 3800 yen Fuji HD <4676.T> -- "Neutral" → "Neutral", 2240 yen → 3000 yen Trend <4704.T> -- "Neutral" → "Neutral", 9000 yen → 1
Genda: (Correction) Partial correction of financial results presentation materials
JP Movers | Sumitomo Pharma Rose 16.95%, Leading Nikkei 225 Components, Mitsubishi Heavy Industries Topped Turnover List
Market sentiment was stable today as Nikkei 225 components continued to trade sideways, with Sumitomo Pharma(4506.JP) being the top gainer today, rising 16.95% to close at 1035.0 yen. In addition, the top loser was SUMCO(3436.JP),falling 3.93% to end at 1051.0 yen.
The Growth 250 fell for the first time in four days, while the popularity of drone-related stocks continues in the Emerging Markets on the 12th.
The Tokyo Stock Exchange Growth Market's 250 Index fell for the first time in four days. The overall Tokyo market was weak, but in the growth sector, ispase <9348.T> rebounded sharply, and stocks like Cover <5253.T>, Cowris <153A.T>, and TENTIAL <325A.T> rose, leading to a robust morning session. However, selling took the lead in the afternoon session. The drone-related stocks continued to be popular, with Blue Innovation <5597.T>, Terra Drone <278A.T>, and ACSL <6232>.
GENDA plummeted due to disappointing earnings report for the first quarter.
The amusement facility operator GENDAL <9166.T> has seen a sharp decline. At one point, it dropped to 808 yen, down 90 yen compared to the previous day. The financial results announced after the close on the 11th for the first quarter of the fiscal year ending in January 2026 (February to April 2025) were viewed as a selling factor. The consolidated operating profit for the first quarter was 1.39 billion yen, a 32.4% decrease year-on-year. The increase in goodwill amortization expenses and the advance occurrence of M&A (mergers and acquisitions) related costs have increased the cost burden. The full-year operating profit financial estimate is 10.5 billion yen.
In the first half [stocks that moved and stocks that were traded].
*Gumi <3903> 640 - Positive feedback on achieving operating profitability and the establishment of a Cryptos management fund. *Sumitomo Pharma <4506> 1035 +150 Daiwa Securities upgraded its investment rating. *ANYCOLOR <5032> 4785 +690 Positive feedback on forecasts for double-digit growth and dividend increases this term. *Proredo Partners <7034> 562 +80 Revised upward its performance forecasts due to contributions from the fund business. *Toho Titanium <5727> 1261 +141 JX Metals President.